DNM1L, a key prognostic predictor for gastric adenocarcinoma, is involved in cell proliferation, invasion, and apoptosis
Open Access
- 11 July 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (3) , 3635-3641
Abstract
Dynamin‑1‑like protein (DNM1L) encodes a member of the dynamin superfamily of GTPases. It mediates mitochondrial and peroxisomal division and is involved in the regulation of apoptosis. However, its role in gastric cancer remains unclear. MKN‑45 gastric cancer cells were transfected with short hairpin RNA (shRNA) to suppress DNM1L expression. MTT, flow cytometry, and Transwell assays were used to detect the changes in cell proliferation, apoptosis, and invasion, respectively. Immunohistochemistry was used to detect DNM1L expression in gastric adenocarcinoma specimens, and the association of DNM1L expression with clinicopathological features and prognosis was analyzed. After the suppression of endogenous DNM1L expression in MKN‑45 cells with shRNA, cell proliferation and invasion rates were significantly reduced, whereas apoptosis was significantly increased (all P<0.01). The expression of DNM1L was significantly higher in gastric adenocarcinoma specimens compared with that in pericarcinoma tissues (P<0.001). The expression of DNM1L increased with increasing infiltration depth, lymphatic metastasis, and higher tumor node metastasis stage (P<0.05). The expression of DNM1L associated negatively with prognosis (P<0.01). DNM1L plays a critical role in the proliferation, invasion and apoptosis of human gastric adenocarcinoma. DNM1L expression has prognostic significance for the survival of patients with gastric adenocarcinoma.Keywords
This publication has 23 references indexed in Scilit:
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trialThe Lancet Oncology, 2013
- Targeting cellular metabolism to improve cancer therapeuticsCell Death & Disease, 2013
- Mitochondrial quality, dynamics and functional capacity in Parkinson’s disease cybrid cell lines selected for Lewy body expressionMolecular Neurodegeneration, 2013
- Mitochondrial Dysfunction in CancerFrontiers in Oncology, 2013
- Depletion of mitochondrial fission factor DRP1 causes increased apoptosis in human colon cancer cellsBiochemical and Biophysical Research Communications, 2012
- Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorderCurrent Opinion in Neurobiology, 2011
- A receptor tyrosine kinase inhibitor, Tyrphostin A9 induces cancer cell death through Drp1 dependent mitochondria fragmentationBiochemical and Biophysical Research Communications, 2011
- Comparative epidemiology of gastric cancer between Japan and ChinaWorld Journal of Gastroenterology, 2011
- Dynamic regulation of mitochondrial fission through modification of the dynamin‐related protein Drp1Annals of the New York Academy of Sciences, 2010
- Management of gastric cancer in OntarioJournal of Surgical Oncology, 2010